Featured Firms
Presented by BigVoodoo
It seemed like a logical plan. A pharmaceutical giant that wanted to expand its cancer treatment offerings found a small biotech company with an innovative drug on the fast track for FDA approval, and the two engaged in a strategic alliance. But months later, the biotech company was embroiled in charges of false statements made to the investing public, faulty execution of clinical trials, alleged misrepresentation to the FDA, and more. How did such a promising partnership go so wrong?
December 05, 2003 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS